Pharmaceutical companies have corrected sharply from their highs but it is difficult to say that the worst is behind.
Nifty Pharma index underperformed for the first time in seven years, falling 5.5 per cent.
Sectors like steel, power and large stressed corporates form 30% of the total bad loans.
Since January 2015, 42 stocks on the SME IPO index have at least more than doubled.
CDSL would become the first depository to get listed in India.
Goldman Sachs expects earnings to grow at 14 per cent this year and 18 per cent next year.
Select financial, auto and auto ancillaries are available at relatively attractive valuation.
Once a stock is excluded from the list of F&O securities, it will not be considered for re-inclusion for one year.
The Nifty has gained about 17.7 per cent so far this year.
The stock has seen a steady build-up in open interest and is likely to gain 4-5 per cent more.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon